PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report

Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first‐line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both thera...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Lee, Robin, Peels, Barbara, Koopman‐Esseboom, Corine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224780/
https://www.ncbi.nlm.nih.gov/pubmed/28096983
http://dx.doi.org/10.1002/ccr3.748
_version_ 1782493419708350464
author van der Lee, Robin
Peels, Barbara
Koopman‐Esseboom, Corine
author_facet van der Lee, Robin
Peels, Barbara
Koopman‐Esseboom, Corine
author_sort van der Lee, Robin
collection PubMed
description Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first‐line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both therapeutics.
format Online
Article
Text
id pubmed-5224780
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52247802017-01-17 PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report van der Lee, Robin Peels, Barbara Koopman‐Esseboom, Corine Clin Case Rep Case Reports Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first‐line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both therapeutics. John Wiley and Sons Inc. 2016-11-23 /pmc/articles/PMC5224780/ /pubmed/28096983 http://dx.doi.org/10.1002/ccr3.748 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
van der Lee, Robin
Peels, Barbara
Koopman‐Esseboom, Corine
PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
title PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
title_full PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
title_fullStr PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
title_full_unstemmed PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
title_short PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
title_sort pde3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224780/
https://www.ncbi.nlm.nih.gov/pubmed/28096983
http://dx.doi.org/10.1002/ccr3.748
work_keys_str_mv AT vanderleerobin pde3inhibitionwithenoximoneasfirstlinetherapyforseverepersistentpulmonaryhypertensionofthenewbornduringneonataltransportacasereport
AT peelsbarbara pde3inhibitionwithenoximoneasfirstlinetherapyforseverepersistentpulmonaryhypertensionofthenewbornduringneonataltransportacasereport
AT koopmanesseboomcorine pde3inhibitionwithenoximoneasfirstlinetherapyforseverepersistentpulmonaryhypertensionofthenewbornduringneonataltransportacasereport

Ejemplares similares